| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1476-5381.1996.TB15341.X |
| P8608 | Fatcat ID | release_avmodsr3trbbjca2ebybgs6ska |
| P932 | PMC publication ID | 1909568 |
| P698 | PubMed publication ID | 8732278 |
| P5875 | ResearchGate publication ID | 14470781 |
| P2093 | author name string | Dalpiaz A | |
| Borea PA | |||
| Varani K | |||
| Gessi S | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets | Q28644646 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein. | Q34318748 | ||
| Nomenclature and classification of purinoceptors. | Q34324355 | ||
| Soluble and membrane-associated human low-affinity adenosine binding protein (adenotin): properties and homology with mammalian and avian stress proteins | Q34352397 | ||
| Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells | Q34660775 | ||
| 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo | Q36308893 | ||
| The thermodynamics of the self-association of the reduced and carboxymethylated form of apoA-II from the human high density lipoprotein complex | Q39075296 | ||
| Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats | Q40996025 | ||
| [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain | Q41954440 | ||
| Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes | Q42205750 | ||
| A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate | Q42229597 | ||
| Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models | Q42700371 | ||
| Inhibition of platelet aggregation by adenosine receptor agonists | Q48114360 | ||
| Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity | Q48398094 | ||
| Identification of a novel high affinity adenosine binding protein from bovine striatum | Q48462972 | ||
| A rapid filtration assay for soluble receptors using polyethylenimine-treated filters | Q48789289 | ||
| 3H5?-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum | Q53838720 | ||
| Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration | Q57903620 | ||
| Thermodynamic analysis of agonist and antagonist binding to membrane-bound and solubilized A1 adenosine receptors | Q60050359 | ||
| Ra Adenosine receptors in human platelets | Q61012553 | ||
| Adenosine binding sites of rat pheochromocytoma PC 12 cell membranes: partial characterization and solubilization | Q68058221 | ||
| A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid | Q68494696 | ||
| Comparison of three paf-acether receptor antagonist ginkgolides | Q69846304 | ||
| Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations | Q69905458 | ||
| Binding thermodynamics of adenosine A2a receptor ligands | Q71676594 | ||
| Purification and characterization of an adenotin-like adenosine binding protein from human platelets | Q72124037 | ||
| 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation | Q72505516 | ||
| Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes | Q72857155 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1693-1701 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding | |
| P478 | volume | 117 |
| Q41961480 | 3H‐SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes |
| Q27335053 | A new drug design targeting the adenosinergic system for Huntington's disease |
| Q33849871 | A(2A) adenosine receptors in human peripheral blood cells |
| Q54575533 | Activation of endothelial nitric oxide synthase is dependent on its interaction with globular actin in human umbilical vein endothelial cells |
| Q45298554 | Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease |
| Q39182356 | Adenosine deaminase activity modulation by some street drug: molecular docking simulation and experimental investigation |
| Q43895095 | Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. |
| Q24323906 | Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor |
| Q44643492 | Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields |
| Q26799623 | Blood cells: an historical account of the roles of purinergic signalling |
| Q43582719 | Blunted adenosine A2a receptor function in platelets in patients with major depression |
| Q50586483 | C-nucleoside analogues of furanfurin as ligands to A1 adenosine receptors |
| Q43176977 | Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 binding |
| Q39462819 | Characterization of vasodilatory adenosine receptors in equine digital veins |
| Q64996165 | Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis. |
| Q54573815 | Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection |
| Q47986048 | Design, Synthesis, and Biological Evaluation of a Second Generation of Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as Potent and Selective A2A Adenosine Receptor Antagonists |
| Q22254619 | Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects |
| Q42046896 | Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils |
| Q36304557 | Effects of a Proprietary Standardized Orthosiphon stamineus Ethanolic Leaf Extract on Enhancing Memory in Sprague Dawley Rats Possibly via Blockade of Adenosine A 2A Receptors |
| Q37380734 | Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. |
| Q35790230 | Heterologous expression of functional G‐protein‐coupled receptors inCaenorhabditis elegans |
| Q34316077 | Interaction of SSR161421, a novel specific adenosine A3 receptor antagonist with adenosine A3 receptor agonists both in vitro and in vivo |
| Q30440914 | New insights into the regulation of inflammation by adenosine |
| Q38205485 | Novel thiazole derivatives: a patent review (2008 - 2012. Part 2). |
| Q38753350 | Purinergic regulation of the immune system |
| Q41456002 | Purinoceptors and platelet aggregation |
| Q40647461 | Recent developments in the field of A2A and A3 adenosine receptor antagonists |
| Q34277485 | Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells |
| Q33292715 | Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we? |
| Q57708175 | Synthesis of Novel Pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives: Potent and Selective Adenosine A3Receptor Antagonists |
| Q36993161 | The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation |
| Q35132147 | The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. |
| Q41169804 | The potent, indirect adenosine monophosphate- activated protein kinase activator R419 attenuates mitogen-activated protein kinase signaling, inhibits nociceptor excitability, and reduces pain hypersensitivity in mice |
| Q42820096 | Wound healing effects of noni (Morinda citrifolia L.) leaves: a mechanism involving its PDGF/A2A receptor ligand binding and promotion of wound closure. |
Search more.